Jam
-
Argo Announces Grant of Incentive Stock Options
Argo Living Soils Corp. (CSE: ARGO) granted 1.8 million incentive stock options at $0.65/share to executives, directors, and consultants, immediately vested with a 2028 expiration. The move aligns stakeholders with the company’s expansion in graphene-enhanced concrete and organic fertilizers, despite potential 4.7% shareholder dilution. A four-month trading lockup aims to stabilize stock liquidity while analysts highlight accelerated vesting as a strategic push for near-term milestones. With shares trading below the strike price at $0.58, the package signals confidence in upcoming commercialization of eco-technologies, aligning with global sustainability initiatives like the U.S. Inflation Reduction Act.
-
Mineralys Therapeutics Presents Late-Breaking Phase 3 Data on Lorundrostat for Uncontrolled or Resistant Hypertension at ESH 2025
Mineralys Therapeutics’ lorundrostat, a novel aldosterone synthase inhibitor, demonstrated strong Phase 3 results in treating resistant hypertension across 1,000+ patients. The trial showed sustained systolic reductions of 19.0 mmHg (11.7 mmHg vs placebo) at 12 weeks and a favorable safety profile with 0.1% serious adverse events. Exceeding FDA efficacy benchmarks, the therapy achieved dual Phase 3 validation and potentially reduces cardiovascular risk by 20-40%. With patent protection through 2041 and a projected $10B+ market opportunity, Mineralys plans Q1 2026 regulatory submission. The company’s $1.2B market cap signals growth potential amid rising global demand for precision hypertension treatments.
-
Pure Energy Minerals Appoints New Board Director
Pure Energy Minerals appointed Cam Hosie, SLB’s New Energy SVP and former 8 Rivers CEO, to its board, enhancing expertise in decarbonization technologies and lithium extraction. Hosie’s leadership strengthens ties to SLB’s $3.2B R&D infrastructure, potentially accelerating Nevada brine projects under their 2019 partnership. His appointment aligns with rising lithium demand and SLB’s focus on modular direct lithium extraction (DLE) systems. While analysts highlight strategic advantages for tech commercialization and EV supply chains, challenges include leadership transition risks and market skepticism. The move follows Patrick Galletti’s departure, reflecting sector trends prioritizing operational expertise amid global lithium market shifts.
-
Battery X Metals Develops Next-Gen Rebalancing Tech for Second-Largest U.S. Out-of-Warranty EV Market
Battery X Metals (BATXF) is targeting aging EV batteries with its rebalancing technology, focusing on Nissan Leaf, the second-largest out-of-warranty EV cohort in the U.S. Partnering with Factor E Motors, the company’s Prototype 2.0 demonstrated 54% capacity restoration in NRC tests, aiming to undercut battery replacement costs by 60-70%. Targeting a $900M+ North American market by 2028, plans include expanding to Ford and Chevy models by 2026. The approach could reduce lithium demand by 18,000 tons annually, aligning with sustainability goals. CEO Massimo Bressi emphasizes adaptability as global EV sales hit 17.1 million units, positioning Battery X as a battery health leader amid rising replacement costs.
-
Deep Track Capital Responds to ISS Proxy Advisory Recommendation
Deep Track Capital (14.82% DVAX shareholder) condemns ISS’s favorable review of Dynavax’s board ahead of its 2025 Annual Meeting, urging governance reforms and new directors. It cites ISS’s alleged dismissal of critical issues: Heplisav’s missed 2024 sales ($275M target) and market share decline (43% Q1 2025), lax capital allocation, and a staggered board structure. Dynavax’s 23% YTD stock drop and 40-point TSR lag vs. Nasdaq Biotech Index underscore concerns. Deep Track criticizes ISS for overlooking governance gaps and misrepresenting settlement talks, advocating for nominees with vaccine expertise to drive strategic shifts. The clash reflects broader activist pressure on biotech governance.
-
Sunnova Receives NYSE Notice Over Delayed 10-Q Filing
Sunnova Energy International Inc. is noncompliant with NYSE listing rules after delaying its Q1 2025 financial filing due to prolonged debt restructuring negotiations. The solar provider received an NYSE notice and has until November 19, 2025, to submit the overdue report, with possible delisting risks if unresolved. Resource prioritization toward debt discussions has hampered reporting processes, as flagged in prior SEC disclosures. Analysts note the delay may heighten investor concerns about liquidity in the residential solar sector amid rising rates and regulatory challenges. Shares continue trading under “NOVA” during the grace period.
-
California American Water Announces Outstanding Water Quality Results for Customers
California American Water unveiled its 2024 Consumer Confidence Reports, confirming compliance with EPA and California water quality standards. The reports detail drinking water sources, detected substances, and public health guidance, featuring updated visuals and simplified language to improve accessibility. President Kevin Tilden highlighted the consistent water excellence and educational value of the documents. Residents can access localized data via the company’s online portal using zip codes. As the largest U.S. public water utility, parent company American Water serves over 14 million people nationwide. Its California subsidiary provides water services to 700,000 residents, prioritizing tech innovation and operational transparency.
-
John O. Larsen, Utility and Customer Engagement Leader, Joins PG&E Board of Directors
PG&E Corporation appointed utility industry veteran John O. Larsen to its Board of Directors following shareholder approval. Larsen, former CEO of Alliant Energy, brings 36 years of experience, including leadership in renewable energy expansion and grid modernization through initiatives like the Clean Energy Blueprint. His appointment reinforces PG&E’s focus on safety, infrastructure resilience, and customer-centric innovation as California accelerates decarbonization. Board Chair Kerry W. Cooper highlighted Larsen’s operational expertise and sustainable energy transition leadership. Larsen expressed commitment to advancing PG&E’s climate-resilient grid goals under CEO Patti Poppe. He will join PG&E’s Safety and Compensation committees, leveraging governance experience from roles at industry organizations. PG&E serves 16 million customers, prioritizing wildfire safety and grid upgrades.
-
Kroger Honored with Bell Seal for Workplace Mental Health Fourth Year Running
Kroger, a leading U.S. grocery retailer, received Mental Health America’s 2025 Gold Bell Seal for its workplace mental health initiatives, a distinction awarded to only 40% of applicants. The company earned a perfect holistic wellness score through programs like subsidized counseling, stress management resources, flexible scheduling, and leadership training. As 76% of U.S. workers report moderate-to-high stress levels, Kroger’s focus on psychological safety addresses burnout and retention challenges. MHA’s rigorous audit recognized Kroger’s emphasis on crisis response, inclusion, and team-building. Analysts note this proactive approach strengthens competitiveness in the high-turnover retail sector, aligning employee well-being with business success.
-
Intermountain Health and Perimeter Medical Imaging Study OCT & AI’s Impact on Reducing Cancer Reoperations and Associated Clinical, Social, and Economic Outcomes
Perimeter Medical Imaging AI partners with Intermountain Health to reduce cancer reoperation rates using advanced OCT imaging and AI. The collaboration, via a Development Support Agreement, will first analyze breast-conserving surgery outcomes to validate the clinical and economic impact of Perimeter’s FDA-cleared S-Series OCT and upcoming AI-driven B-Series device. Intermountain’s integrated healthcare-insurance model enables comprehensive assessment of reoperation costs and patient outcomes. CEO Adrian Mendes noted the data will inform FDA strategies and expansion into new surgical areas. A 2023 study estimated $1.2B annual U.S. costs for repeat breast cancer surgeries, which Perimeter’s real-time margin assessment aims to reduce.